Julie Ann Mayer - Concepedia

Author

Julie Ann Mayer

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

J MAYER, J Mayer, J. Mayer, Julie A Mayer, Julie A. Mayer, Julie Ann Mayer, Julie Mayer, Julie Ann Mayer, Mayer, J., Mayer, Julie

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Biopeptide (United States)University of Southern California European Clinical Research Infrastructure Network Centre d'Étude et de Recherche Travail Organisation Pouvoir

About

Julie Ann Mayer is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.7K
2	Engineering	2	2	88
3	Public Health	2	2	61
4	Health Sciences	1	1	14
5	Natural Sciences	1	1	24

Julie Ann Mayer

Publications

Citations

H-Index

Page 1

	Year	Citations
Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration Maksim V. Plikus, Julie Ann Mayer, Damon de la Cruz, Nature Skin DevelopmentDevelopmental BiologyCell ActivationMedicineCutaneous Biology	2008	744
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread Sunila Pradeep, Seung Wook Kim, Sherry Y. Wu, Cancer Cell Tumoral PathologyMedicineGynecologyOncologyGynecology Oncology	2014	320
A Novel Platform for Detection of CK+ and CK− CTCs Chad V. Pecot, Farideh Z. Bischoff, Julie Ann Mayer, Cancer Discovery	2011	207
Estrogen Induces c-myc Gene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor Chunyu Wang, Julie Ann Mayer, Abhijit Mazumdar, Molecular Endocrinology Breast OncologyC-myc ExpressionGeneticsEstrogen ReceptorAp-1 Transcription Factor	2011	186
Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells Lü Chen, Julie Ann Mayer, Tibor I. Krisko, Cancer Research Breast OncologyChemoprevention StrategyP38 KinaseCell DeathP38 Blockade	2009	136
FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform Julie Ann Mayer, Tam Pham, Karina Wong, Cancer Genetics Her2 StatusMicrofluidic Cee™ PlatformEngineeringMedicineBioanalysis	2011	77
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE) Chunyu Wang, Iván P. Uray, Abhijit Mazumdar, Breast Cancer Research and Treatment Breast OncologyMedicineHormonal ReceptorSlc22a5/octn2 ExpressionBreast Cancer	2012	58
Discordance in <scp><i>HER2</i></scp> gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer Savitri Krishnamurthy, Farideh Z. Bischoff, Julie Ann Mayer, Cancer Medicine	2013	46
Conversion of the Nipple to Hair-Bearing Epithelia by Lowering Bone Morphogenetic Protein Pathway Activity at the Dermal-Epidermal Interface Julie Ann Mayer, John Foley, Damon de la Cruz, American Journal Of Pathology Dermal-epidermal InterfaceDevelopmental BiologyHair-bearing EpitheliaMammary GlandMorphogenesis	2008	43
Structure–activity relationship analysis tools: Validation and applicability in predicting carcinogens Julie Ann Mayer, M Cheeseman, Michelle L. Twaroski Regulatory Toxicology and Pharmacology Systems PharmacologyCancer EpidemiologyPredictive ToxicologyMedicineToxicology	2007	42

Page 1